APA (7th ed.) Citation

Jixiang Zhang, Xiaohan Wu, Shuchun Wei, Chuan Liu, Xiaoli Wang, & Weiguo Dong. (2022). Identified potential biomarkers may predict primary nonresponse to infliximab in patients with ulcerative colitis. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Jixiang Zhang, Xiaohan Wu, Shuchun Wei, Chuan Liu, Xiaoli Wang, and Weiguo Dong. Identified Potential Biomarkers May Predict Primary Nonresponse to Infliximab in Patients with Ulcerative Colitis. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Jixiang Zhang, et al. Identified Potential Biomarkers May Predict Primary Nonresponse to Infliximab in Patients with Ulcerative Colitis. Taylor & Francis Group, 2022.